Emerging Roles of Dyslipidemia and Hyperglycemia in Diabetic Retinopathy: Molecular Mechanisms and Clinical Perspectives
Diabetic retinopathy (DR) is a significant cause of vision loss and a research subject that is constantly being explored for new mechanisms of damage and potential therapeutic options. There are many mechanisms and pathways that provide numerous options for therapeutic interventions to halt disease...
Main Authors: | Hussain Rao, Jonathan A. Jalali, Thomas P. Johnston, Peter Koulen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2021.620045/full |
Similar Items
-
Association of serum lipid levels with diabetic retinopathy
by: Hulya Aybek, et al.
Published: (2013-06-01) -
Macular oedema as manifestation of diabetic retinopathy
by: Mukharram M. Bikbov, et al.
Published: (2017-10-01) -
Antioxidant Drug Therapy Approaches for Neuroprotection in Chronic Diseases of the Retina
by: Andrew J. Payne, et al.
Published: (2014-01-01) -
Prevention of macular oedema after cataract surgery in patients with diabetes mellitus
by: Irina A. Bashina, et al.
Published: (2017-12-01) -
Reactive Oxygen Species-Mediated Damage of Retinal Neurons: Drug Development Targets for Therapies of Chronic Neurodegeneration of the Retina
by: Landon J. Rohowetz, et al.
Published: (2018-10-01)